A spokesperson confirmed the Danish drugmaker has asked U.S. regulators to clear an oral version of its weight loss drug ...

Doctors and patients have been hoping for a pill version that would be easier to take, in contrast to an injectable.

Researchers discovered an unexpected Alzheimer’s preventative in the form of a very common sleeping pill you might already be ...

Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

While not officially approved, Eli Lilly says it could be an alternative to injectable drugs like ozempic as a once-a-day ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective ...

Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Gen Z (66%), millennials (74%), and Gen X (68%) surveyed said they'll give up the money. Opendoor put it in perspective, citing the average home price in the U.S is $419,200—that means sellers ...

A former AFL gun has come up to clutch to lead his reigning premier division one AdFL side to a dramatic victory in round one of the season. See the 10 things we learned across the state’s ...